tiprankstipranks
Calidi Biotherapeutics (CLDI)
XASE:CLDI
US Market
CLDI
Calidi Biotherapeutics
RESEARCH TOOLSreports
Want to see CLDI full AI Analyst Report?

Calidi Biotherapeutics (CLDI) Financial Statements

360 Followers

Calidi Biotherapeutics Financial Overview

Calidi Biotherapeutics's market cap is currently $2.95M. The company's EPS TTM is $-0.57; its P/E ratio is -0.52; Calidi Biotherapeutics is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 45.00K$ 449.00K
Gross Profit$ -1.65M$ 0.00$ -1.26M$ -229.00K$ 355.00K
Operating Income$ -20.24M$ -21.78M$ -28.99M$ -23.13M$ -10.48M
EBITDA$ -18.59M$ -19.73M$ -24.20M$ -25.00M$ -9.45M
Net Income$ -19.91M$ -22.14M$ -29.22M$ -25.43M$ -10.93M
Balance Sheet
Cash & Short-Term Investments$ 5.60M$ 9.59M$ 2.05M$ 372.00K$ 2.14M
Total Assets$ 8.86M$ 14.18M$ 10.02M$ 2.60M$ 3.39M
Total Debt$ 2.56M$ 7.04M$ 7.24M$ 5.99M$ 5.18M
Net Debt$ -3.04M$ -2.56M$ 5.19M$ 5.62M$ 3.04M
Total Liabilities$ 5.10M$ 12.21M$ 18.25M$ 53.04M$ 26.00M
Stockholders' Equity$ 3.76M$ 1.53M$ -8.23M$ -50.44M$ -22.61M
Cash Flow
Free Cash Flow$ -21.41M$ -19.71M$ -27.57M$ -13.64M$ -7.98M
Operating Cash Flow$ -21.29M$ -19.69M$ -26.98M$ -13.21M$ -7.77M
Investing Cash Flow$ -170.00K$ -16.00K$ -478.00K$ -494.00K$ -215.00K
Financing Cash Flow$ 17.46M$ 27.36M$ 29.04M$ 12.09M$ 9.81M
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

Income Statement >

Calidi Biotherapeutics Debt to Assets

Balance Sheet >

Calidi Biotherapeutics Cash Flow

Cash Flow >

Calidi Biotherapeutics Forecast EPS vs Actual EPS

Earnings >